000			01790 a2200505 4500
005			20250516180857.0
264		0	_c20140616
008			201406s 0 0 eng d
022			_a1980-5322
024	7		_a10.6061/clinics/2013(10)10 _2doi
040			_aNLM _beng _cNLM
100	1		_aSong, Yinghua
245	0	0	_aAntifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice. _h[electronic resource]
260			_bClinics (Sao Paulo, Brazil) _cOct 2013
300			_a1350-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic
650	0	4	_aAnticarcinogenic Agents _xpharmacology
650	0	4	_aBleomycin
650	0	4	_aCarotenoids _xpharmacology
650	0	4	_aCollagen Type I _xblood
650	0	4	_aCollagen Type I, alpha 1 Chain
650	0	4	_aCollagen Type III _xblood
650	0	4	_aEndothelin-1 _xblood
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aFibrosis
650	0	4	_aImmunohistochemistry
650	0	4	_aLung _xdrug effects
650	0	4	_aMatrix Metalloproteinase 1 _xblood
650	0	4	_aMice
650	0	4	_aMice, Inbred C3H
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aScleroderma, Systemic _xchemically induced
650	0	4	_aSkin _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xblood
650	0	4	_aVitamin A _xanalogs & derivatives
700	1		_aZhu, Lubing
700	1		_aLi, Ming
773	0		_tClinics (Sao Paulo, Brazil) _gvol. 68 _gno. 10 _gp. 1350-7
856	4	0	_uhttps://doi.org/10.6061/clinics/2013(10)10 _zAvailable from publisher's website
999			_c23249126 _d23249126